Autolus Therapeutics announce new time for investor call to discuss data presented at the 63rd ASH Annual Meeting & Exposition
06 December 2021 - 11:00PM
Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage
biopharmaceutical company developing next-generation programmed T
cell therapies, today announced it will hold a conference call to
discuss the data being presented at the 63rd American Society
of Hematology (ASH) Annual Meeting & Exposition, being held
between December 11-14, 2021.
Note this is a change to the
timing announced previously.
New timing of investor call
Management will host a conference call and
webcast on Monday, December 13, 2021, at 8:00 am ET/1:00 pm
GMT to discuss the ASH data. To listen to the webcast and view the
accompanying slide presentation, please go to the events section of
Autolus’ website.
Conference Dial in:
- United States and Canada (866) 679-5407
- International (409) 217-8320
- Conference ID 31044873
Replay:A replay will be
available for one week following the call
- United States and Canada (855)
859-2056
- International (404) 537-3406
- Conference ID 31044873
About Autolus Therapeutics
plcAutolus is a clinical-stage biopharmaceutical company
developing next-generation, programmed T cell therapies for the
treatment of cancer. Using a broad suite of proprietary and modular
T cell programming technologies, the Company is engineering
precisely targeted, controlled and highly active T cell therapies
that are designed to better recognize cancer cells, break down
their defense mechanisms and eliminate these cells. Autolus has a
pipeline of product candidates in development for the treatment of
hematological malignancies and solid tumors. For more information,
please visit www.autolus.com.
Contact:
Lucinda Crabtree, PhDVice President, Business
Strategy and Planning+44 (0) 7587 372
619 l.crabtree@autolus.com
Julia Wilson+44 (0) 7818
430877j.wilson@autolus.com
Susan A. NoonanS.A. Noonan
Communications+1-212-966-3650susan@sanoonan.com
Autolus Therapeutics (NASDAQ:AUTL)
Historical Stock Chart
From Apr 2024 to May 2024
Autolus Therapeutics (NASDAQ:AUTL)
Historical Stock Chart
From May 2023 to May 2024